BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $1.31B
1-Year Est. Return 142.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+142.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.51B
AUM Growth
+$707M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$400M
2
+$33.2M
3
+$4.83M

Top Sells

1
+$110M
2
+$30.9M
3
+$29.8M
4
PHVS icon
Pharvaris
PHVS
+$2.71M
5
IVVD icon
Invivyd
IVVD
+$1.29M

Sector Composition

1 Healthcare 99.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTFL
1
Heartflow Inc
HTFL
$1.92B
$419M 27.81%
+12,448,158
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.6B
$305M 20.23%
10,719,110
CDTX
3
DELISTED
Cidara Therapeutics
CDTX
$289M 19.2%
3,020,990
+520,310
PHVS icon
4
Pharvaris
PHVS
$1.68B
$79.4M 5.27%
3,181,275
-122,106
OLMA icon
5
Olema Pharmaceuticals
OLMA
$1.26B
$67M 4.45%
6,843,954
SVRA icon
6
Savara
SVRA
$1.14B
$62.8M 4.17%
17,600,621
DNTH icon
7
Dianthus Therapeutics
DNTH
$3.76B
$51.8M 3.44%
1,315,892
-1,166,358
SLDB icon
8
Solid Biosciences
SLDB
$637M
$48.8M 3.24%
7,911,669
UPB
9
Upstream Bio Inc
UPB
$439M
$45.9M 3.05%
2,439,538
RPID icon
10
Rapid Micro Biosystems
RPID
$183M
$28.2M 1.87%
8,434,560
TNGX icon
11
Tango Therapeutics
TNGX
$2.35B
$22.8M 1.51%
2,712,008
CABA icon
12
Cabaletta Bio
CABA
$320M
$22.6M 1.5%
9,677,125
KYTX icon
13
Kyverna Therapeutics
KYTX
$550M
$20.2M 1.34%
3,368,370
ANNX icon
14
Annexon
ANNX
$906M
$16M 1.06%
5,249,069
XFOR icon
15
X4 Pharmaceuticals
XFOR
$407M
$8.33M 0.55%
2,436,588
+1,872,729
AVIR icon
16
Atea Pharmaceuticals
AVIR
$473M
$7.21M 0.48%
2,485,638
XLO icon
17
Xilio Therapeutics
XLO
$41.1M
$3.85M 0.26%
4,566,817
MRSN
18
DELISTED
Mersana Therapeutics
MRSN
$2.69M 0.18%
346,545
-2
CCCC icon
19
C4 Therapeutics
CCCC
$304M
$2.47M 0.16%
1,111,910
IPSC icon
20
Century Therapeutics
IPSC
$242M
$1.76M 0.12%
3,538,609
-1,871,752
NAMSW icon
21
NewAmsterdam Pharma Warrant
NAMSW
$84.9M
$1.71M 0.11%
100,000
IRON icon
22
Disc Medicine
IRON
$2.53B
– –
-583,500
IVVD icon
23
Invivyd
IVVD
$516M
– –
-1,799,595
NUVL icon
24
Nuvalent
NUVL
$8.04B
– –
-1,447,267